Literature DB >> 2528278

Reversal of left ventricular dilatation, hypertrophy, and dysfunction by valve replacement in aortic regurgitation.

M J Roman1, L Klein, R B Devereux, P Kligfield, N W Niles, C Hochreiter, O W Isom, J S Borer.   

Abstract

Although aortic valve replacement for aortic regurgitation relieves left ventricular volume overload, ventricular geometry does not consistently normalize. To assess the extent, determinants, and functional consequences of reversal of left ventricular dilatation and hypertrophy, 38 patients with severe aortic regurgitation were studied pre- and postoperatively by serial echocardiography and radionuclide cineangiography. Left ventricular end-diastolic dimension normalized in 58% of patients by 9 +/- 6 months postoperatively, at which time 50% of patients had normalized mass; cumulative normalization rose to 66% for end-diastolic dimension and 68% for left ventricular mass during further follow-up. All patients who had normalized end-diastolic dimension also had normal postoperative ejection fractions (mean 61 +/- 8%). In contrast, patients in whom the left ventricle remained dilated had a 42% prevalence of subnormal postoperative left ventricular ejection fraction. Preoperative left ventricular end-systolic dimension less than or equal to 55 mm identified 86% of patients in whom end-diastolic dimension normalized, whereas end-systolic dimension exceeded 55 mm in 81% of those with persistent dilatation; other proposed preoperative predictors of operative outcome correctly identified lower proportions (from 59% to 71%) of patients in whom left ventricular size did or did not normalize. In conclusion, aortic valve replacement resulted in normalized left ventricular chamber size and mass in two thirds of the patients selected for operation by current criteria; favorable geometric outcome is associated with persistence or recovery of normal left ventricular function.

Entities:  

Mesh:

Year:  1989        PMID: 2528278     DOI: 10.1016/0002-8703(89)90272-x

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  5 in total

Review 1.  Management decisions in valvular heart disease: the role of radionuclide-based assessment of ventricular function and performance.

Authors:  J S Borer; D Wencker; C Hochreiter
Journal:  J Nucl Cardiol       Date:  1996 Jan-Feb       Impact factor: 5.952

2.  Survival after Aortic Valve Replacement for Aortic Regurgitation: Prediction from Preoperative Contractility Measurement.

Authors:  Jeffrey S Borer; Phyllis G Supino; Edmund McM Herrold; Antony Innasimuthu; Clare Hochreiter; Karl Krieger; Leonard N Girardi; O Wayne Isom
Journal:  Cardiology       Date:  2018-08-23       Impact factor: 1.869

3.  Prediction of indications for valve replacement among asymptomatic or minimally symptomatic patients with chronic aortic regurgitation and normal left ventricular performance.

Authors:  J S Borer; C Hochreiter; E M Herrold; P Supino; M Aschermann; D Wencker; R B Devereux; M J Roman; M Szulc; P Kligfield; O W Isom
Journal:  Circulation       Date:  1998-02-17       Impact factor: 29.690

Review 4.  Are vasodilators still indicated in the treatment of severe aortic regurgitation?

Authors:  Jocelyn Inamo; Maurice Enriquez-Sarano
Journal:  Curr Cardiol Rep       Date:  2007-04       Impact factor: 2.931

Review 5.  Left ventricular hypertrophy. Prevalence in older patients and management.

Authors:  E Paciaroni; A Fraticelli
Journal:  Drugs Aging       Date:  1995-04       Impact factor: 3.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.